These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 8895234)

  • 21. NMDA receptor antagonists inhibit opiate antinociceptive tolerance and locomotor sensitization in rats.
    Mendez IA; Trujillo KA
    Psychopharmacology (Berl); 2008 Feb; 196(3):497-509. PubMed ID: 17994223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ionotropic glutamatergic neurotransmission in the ventral tegmental area modulates DeltaFosB expression in the nucleus accumbens and abstinence syndrome in morphine withdrawal rats.
    Wang HL; Xiang XH; Guo Y; Wu WR; Cao DY; Wang HS; Zhao Y
    Eur J Pharmacol; 2005 Dec; 527(1-3):94-104. PubMed ID: 16303124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MK-801, but not naloxone, attenuates high-dose dextromethorphan-induced convulsive behavior: Possible involvement of the GluN2B receptor.
    Tran HQ; Chung YH; Shin EJ; Tran TV; Jeong JH; Jang CG; Nah SY; Yamada K; Nabeshima T; Kim HC
    Toxicol Appl Pharmacol; 2017 Nov; 334():158-166. PubMed ID: 28916251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.
    Shen KF; Crain SM
    Brain Res; 1997 May; 757(2):176-90. PubMed ID: 9200746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NMDA antagonist modulation of morphine antinociception in female vs. male rats.
    Craft RM; Lee DA
    Pharmacol Biochem Behav; 2005 Apr; 80(4):639-49. PubMed ID: 15820534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent spinal infusion of MK801 blocks spinal tolerance and dependence induced by chronic intrathecal morphine in the rat.
    Dunbar S; Yaksh TL
    Anesthesiology; 1996 May; 84(5):1177-88. PubMed ID: 8624012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
    Juni A; Klein G; Kest B
    Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral effects of MK-801 in morphine-dependent and non-dependent mice.
    Belozertseva I; Zvartau E; Bespalov A
    Life Sci; 1996; 58(4):PL55-61. PubMed ID: 8538362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator.
    Singh P; Sharma B; Gupta S; Sharma BM
    Psychopharmacology (Berl); 2015 Jan; 232(2):465-75. PubMed ID: 25059539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
    Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
    Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic naloxone-induced supersensitivity affects neither tolerance to nor physical dependence on morphine at hypothalamus-pituitary-adrenocortical axis.
    Alcaraz C; Vargas ML; Milanés MV
    Neuropeptides; 1996 Feb; 30(1):29-36. PubMed ID: 8868296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for opiate-activated NMDA processes masking opiate analgesia in rats.
    Célèrier E; Laulin J; Larcher A; Le Moal M; Simonnet G
    Brain Res; 1999 Nov; 847(1):18-25. PubMed ID: 10564731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Height-dependent difference in the expression of naloxone-induced withdrawal jumping behavior in morphine dependent rats.
    Azizi H; Ranjbar-Slamloo Y; Semnanian S
    Neurosci Lett; 2012 May; 515(2):174-6. PubMed ID: 22465245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Memantine presents different effects from MK-801 in motivational and physical signs of morphine withdrawal.
    Maldonado C; Cauli O; Rodríguez-Arias M; Aguilar MA; Miñarro J
    Behav Brain Res; 2003 Sep; 144(1-2):25-35. PubMed ID: 12946592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal.
    Aley KO; Green PG; Levine JD
    J Neurosci; 1995 Dec; 15(12):8031-8. PubMed ID: 8613740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia.
    Harris AC; Rothwell PE; Gewirtz JC
    Psychopharmacology (Berl); 2008 Mar; 196(4):649-60. PubMed ID: 18026718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antinociceptive potentiation and attenuation of tolerance by intrathecal electric stimulation in rats.
    Lin CR; Yang LC; You HL; Lee CT; Tai MH; Tan PH; Lin MW; Cheng JT
    Anesth Analg; 2003 Jun; 96(6):1711-1716. PubMed ID: 12761002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. beta-Lactam antibiotic inhibits development of morphine physical dependence in rats.
    Rawls SM; Baron DA; Kim J
    Behav Pharmacol; 2010 Mar; 21(2):161-4. PubMed ID: 20215965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of morphine analgesia by LPS: role of opioid and NMDA receptors and spinal glia.
    Johnston IN; Westbrook RF
    Behav Brain Res; 2005 Jan; 156(1):75-83. PubMed ID: 15474652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans.
    Bisaga A; Comer SD; Ward AS; Popik P; Kleber HD; Fischman MW
    Psychopharmacology (Berl); 2001 Aug; 157(1):1-10. PubMed ID: 11512037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.